Clinical trial
Alfapump® DSR Feasibility Study in Subjects With Persistent Congestion Due to Heart Failure, Resistant to Loop Diuretic Treatment
NCT04882358 is registered in ClinicalTrials.gov with Sequana Medical N.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alfapump® DSR Feasibility Study in Subjects With Persistent Congestion Due to Heart Failure, Resistant to Loop Diuretic Treatment
- Lead sponsor
- Sequana Medical N.V.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 27, 2021
- Completion date
- December 31, 2024
- Enrollment
- 24 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, volume overload